INDV
Indivior Plc

190
Mkt Cap
$3.11B
Volume
940,785.00
52W High
$25.49
52W Low
$7.62
PE Ratio
35.13
INDV Fundamentals
Price
$25.28
Prev Close
$24.90
Open
$25.05
50D MA
$23.86
Beta
-0.11
Avg. Volume
2.44M
EPS (Annual)
$0.015
P/B
-12.11
Rev/Employee
$1.13M
Loading...
Loading...
News
all
press releases
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th PR Newswire RICHMOND...
PR Newswire·7d ago
News Placeholder
More News
News Placeholder
Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment
Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve...
PR Newswire·8d ago
News Placeholder
What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now?
Does Indivior PLC (INDV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·1mo ago
News Placeholder
All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy
Indivior (INDV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·3mo ago
News Placeholder
Best Momentum Stock to Buy for August 5th
FFIV, INDV and NVT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 5, 2025.
Zacks·3mo ago
News Placeholder
New Strong Buy Stocks for August 5th
ARMN, QUAD, NVST, INDV and BJRI have been added to the Zacks Rank #1 (Strong Buy) List on August 5, 2025.
Zacks·3mo ago
News Placeholder
Indivior PLC (INDV) Tops Q2 Earnings and Revenue Estimates
Indivior (INDV) delivered earnings and revenue surprises of +96.15% and +22.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Indivior (INDV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Indivior (INDV) Moves 5.7% Higher: Will This Strength Last?
Indivior (INDV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·4mo ago

Latest INDV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.